dc.contributor.author |
Lemanu, Daniel |
en |
dc.contributor.author |
Singh, PP |
en |
dc.contributor.author |
Rahman, H |
en |
dc.contributor.author |
Hill, Andrew |
en |
dc.contributor.author |
Babor, R |
en |
dc.contributor.author |
MacCormick, Andrew |
en |
dc.date.accessioned |
2017-10-29T22:19:50Z |
en |
dc.date.issued |
2015-05 |
en |
dc.identifier.citation |
Surgery for Obesity and Related Diseases 11(3):518-524 May 2015 |
en |
dc.identifier.issn |
1878-7533 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/36277 |
en |
dc.description.abstract |
Whilst the early to mid-term efficacy of laparoscopic sleeve gastrectomy (SG) is well established, there is comparatively less detailing of long-term efficacy. The objectives of this study were to evaluate the long-term outcomes of patients undergoing SG at the authors' institution.All patients undergoing SG during the past 5 or more years were eligible. Outcomes included baseline demographic data, preoperative characteristics, percentage excess weight loss (%EWL), co-morbidity improvement and resolution, serum hemoglobin A(1c) (HbA(1c)), serum lipid profile, and the Bariatric Analysis Reporting Outcome System (BAROS) questionnaire. A subset analysis was also performed with patients stratified in to super obese (body mass index ≥ 50 kg/m(2)).There were 96 patients who underwent surgery between March 2007 and July 2008. Of these, 10 declined to participate, 28 were unable to be contacted, and 3 were deceased; therefore, 55 patients were included in the analysis. The mean yearly %EWL to postoperative year 5 was 56% (year 1), 55% (year 2), 46% (year 3), 43% (year 4), and 40% (year 5). Combined improvement and resolution rates at 5 years were 79%, 61%, and 73% for type 2 diabetes, hypertension, and obstructive sleep apnea, respectively. The HbA(1c) was significantly reduced at long-term follow-up. The mean BAROS score was 3.13 (95% CI: 2.4, 3.9). Weight loss outcomes were less favorable in super obese patients.Weight loss outcomes at 5 year follow-up were modest after SG though improvement in co-morbidity status was maintained. |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.publisher |
Elsevier |
en |
dc.relation.ispartofseries |
Surgery for Obesity and Related Diseases |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Obesity, Morbid |
en |
dc.subject |
Weight Loss |
en |
dc.subject |
Laparoscopy |
en |
dc.subject |
Body Mass Index |
en |
dc.subject |
Treatment Outcome |
en |
dc.subject |
Gastrectomy |
en |
dc.subject |
Follow-Up Studies |
en |
dc.subject |
Prospective Studies |
en |
dc.subject |
Time Factors |
en |
dc.subject |
Middle Aged |
en |
dc.subject |
Female |
en |
dc.subject |
Male |
en |
dc.subject |
Surveys and Questionnaires |
en |
dc.title |
Five-year results after laparoscopic sleeve gastrectomy: a prospective study |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1016/j.soard.2014.08.019 |
en |
pubs.issue |
3 |
en |
pubs.begin-page |
518 |
en |
pubs.volume |
11 |
en |
dc.rights.holder |
Copyright: Elsevier |
en |
dc.identifier.pmid |
25614352 |
en |
pubs.end-page |
524 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
473874 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
South Auckland clinical school |
en |
pubs.org-id |
Surgery Department |
en |
dc.identifier.eissn |
1878-7533 |
en |
pubs.record-created-at-source-date |
2017-10-30 |
en |
pubs.dimensions-id |
25614352 |
en |